Professor Ian Fraze
Molecular Biosciences
vaxxas
Australia
Biography
Professor Ian Frazer is the Chief Executive Officer (CEO) and Research Director of the Translational Research Institute (TRI) in Brisbane, Australia. In his role as CEO, Professor Frazer is charged with leading the $354 million TRI to achieve its mission of being Australia's first institute, and one of only a few in the world, to research, trial and manufacture breakthrough drugs in the one location, once construction is complete in 2012. The TRI will accommodate up to 650 researchers from the four TRI partners: The University of Queensland, Queensland University of Technology, Mater Medical Research Institute and the Princess Alexandra Hospital.
Research Interest
Molecular Biosciences
